HRP20141081T1 - Tikagrelor za lijeäśenje aneurizme abdominalne aorte - Google Patents

Tikagrelor za lijeäśenje aneurizme abdominalne aorte Download PDF

Info

Publication number
HRP20141081T1
HRP20141081T1 HRP20141081AT HRP20141081T HRP20141081T1 HR P20141081 T1 HRP20141081 T1 HR P20141081T1 HR P20141081A T HRP20141081A T HR P20141081AT HR P20141081 T HRP20141081 T HR P20141081T HR P20141081 T1 HRP20141081 T1 HR P20141081T1
Authority
HR
Croatia
Prior art keywords
treatment
ticagrelor
abdominal aortic
aortic aneurysms
abdominal
Prior art date
Application number
HRP20141081AT
Other languages
English (en)
Croatian (hr)
Inventor
Jean-Baptiste Michel
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of HRP20141081T1 publication Critical patent/HRP20141081T1/hr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HRP20141081AT 2007-12-03 2008-12-02 Tikagrelor za lijeäśenje aneurizme abdominalne aorte HRP20141081T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07301616 2007-12-03
PCT/SE2008/051386 WO2009072967A1 (en) 2007-12-03 2008-12-02 Triazolo [4,5-d] pyrimidine compounds for treatment of abdominal aortic aneurysms

Publications (1)

Publication Number Publication Date
HRP20141081T1 true HRP20141081T1 (hr) 2015-01-02

Family

ID=40717966

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20141081AT HRP20141081T1 (hr) 2007-12-03 2008-12-02 Tikagrelor za lijeäśenje aneurizme abdominalne aorte

Country Status (24)

Country Link
US (2) US20100298350A1 (https=)
EP (1) EP2229172B1 (https=)
JP (1) JP5701060B2 (https=)
KR (1) KR101563757B1 (https=)
CN (2) CN103919781A (https=)
AU (1) AU2008331984B2 (https=)
BR (1) BRPI0819458A2 (https=)
CA (1) CA2707488C (https=)
CY (1) CY1115760T1 (https=)
DK (1) DK2229172T3 (https=)
EA (1) EA201000928A1 (https=)
ES (1) ES2522317T3 (https=)
HR (1) HRP20141081T1 (https=)
IL (1) IL205613A (https=)
MX (1) MX2010006101A (https=)
MY (1) MY159656A (https=)
NZ (1) NZ585513A (https=)
PL (1) PL2229172T3 (https=)
PT (1) PT2229172E (https=)
RS (1) RS53635B1 (https=)
SI (1) SI2229172T1 (https=)
UA (1) UA100864C2 (https=)
WO (1) WO2009072967A1 (https=)
ZA (1) ZA201003599B (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102653539B (zh) * 2011-03-01 2014-09-17 秦引林 一种抗血小板聚集化合物及其药物组合
CN102924457A (zh) * 2011-08-12 2013-02-13 上海恒瑞医药有限公司 三唑并嘧啶类衍生物、其制备方法及其用途
WO2013033178A1 (en) 2011-08-30 2013-03-07 University Of Utah Research Foundation Methods and compositions for treating nephrogenic diabetes insipidus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199800019T1 (xx) * 1995-07-11 1998-05-21 Astra Pharmaceuticals Limited Trombosit topaklanmas�n� �nleyici yeni maddeler.
AR017014A1 (es) * 1997-07-22 2001-08-22 Astrazeneca Ab Compuestos de triazolo [4,5-d]pirimidina, composiciones farmaceuticas, uso de los mismos para preparar medicamentos y procesos para la preparacionde dichos compuestos
TWI229674B (en) * 1998-12-04 2005-03-21 Astra Pharma Prod Novel triazolo[4,5-d]pyrimidine compounds, pharmaceutical composition containing the same, their process for preparation and uses
GB0013407D0 (en) * 2000-06-02 2000-07-26 Astrazeneca Ab Forms of a chemical compound
SE0101932D0 (sv) * 2001-05-31 2001-05-31 Astrazeneca Ab Pharmaceutical combinations
WO2009007675A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist

Also Published As

Publication number Publication date
KR101563757B1 (ko) 2015-10-27
EP2229172A4 (en) 2012-12-26
IL205613A0 (en) 2010-11-30
MX2010006101A (es) 2010-10-04
BRPI0819458A2 (pt) 2015-05-05
JP5701060B2 (ja) 2015-04-15
NZ585513A (en) 2012-07-27
EA201000928A1 (ru) 2010-12-30
ES2522317T3 (es) 2014-11-14
CY1115760T1 (el) 2017-01-25
CN101883565A (zh) 2010-11-10
CA2707488A1 (en) 2009-06-11
PT2229172E (pt) 2014-11-03
US20100298350A1 (en) 2010-11-25
RS53635B1 (sr) 2015-04-30
DK2229172T3 (da) 2014-11-10
EP2229172A1 (en) 2010-09-22
JP2011505417A (ja) 2011-02-24
CN103919781A (zh) 2014-07-16
HK1148195A1 (en) 2011-09-02
AU2008331984B2 (en) 2012-08-16
US20150272955A1 (en) 2015-10-01
SI2229172T1 (sl) 2014-12-31
AU2008331984A1 (en) 2009-06-11
PL2229172T3 (pl) 2015-01-30
MY159656A (en) 2017-01-13
IL205613A (en) 2015-04-30
WO2009072967A1 (en) 2009-06-11
EP2229172B1 (en) 2014-09-10
ZA201003599B (en) 2012-10-31
KR20100099175A (ko) 2010-09-10
UA100864C2 (uk) 2013-02-11
CA2707488C (en) 2015-07-28

Similar Documents

Publication Publication Date Title
CY1119380T1 (el) Συνθεσεις, καταλληλες για απο του στοματος χορηγηση, που περιεχουν ενα παραγωγο τριαζολο [4,5-d]πυριμιδινης
UY29093A1 (es) Derivados de 4-oxo-3. 4-dihidroquinazolin-6-carboxamida, inhibidores de b-raf, composiciones que los contienen, procesos de preparación y aplicaiones.
NI201400052A (es) Composiciones farmacéuticas de 7 - ( 6 - ( 2 - hidroxipropano - 2 - il ) piridina - 3 - il ) - 1 - ((trans) - 4 - metoxiciclohexil ) - 3, 4 - dihidropirazino [ 2, 3 - b ] pirazina - 2 ( 1h ) - ona, una forma sólida de las mismas y métodos de su uso
CL2011002956A1 (es) Compuestos derivados de pirrolo[2,3-d]pirimidina, inhibidores de la quinasa janus (jak1); composicion farmaceutica; y uso para el tratamiento de una enfermedad autoinmune, cancer, trastorno mieloproliferativo, una enfermedad inflamatoria o rechazo de trasplante de organos.
CY1122575T1 (el) Φαρμακοτεχνικες μορφες διστρωματικου δισκιου
CY1117815T1 (el) Τοπικο σκευασμα για εναν αναστολεα jak
CL2015000428A1 (es) Uso de un anticuerpo inhibidor de la dimerización de her2 para preparar medicamento para extender el tiempo de progresion de una enfermedad (ttp) o supervivencia en un paciente con cancer de mama metastasico (mbc) (div. sol. n°399-06).
CR11854A (es) Compuestos de piridina
IL211191A0 (en) A process for preparing[1s- [1-alpha, 2-alpha, 3-beta (1s*, 2r*) 5-beta]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3h-1, 2,3-triazolo [4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol and to its intermediates
ECSP099250A (es) USO DE 2-6-(3-amino-piperidin-1-Il)-3-metil-2,4-dioxo-3,4-dihIdro-2H-pIrimidin-1-IlmetIL-4-fluoro-benzonitrilo
CL2011002972A1 (es) Compuestos derivados de imidazol sustituido, moduladores de la actividad de receptores x del higado (lxr); composicion farmaceutica, utiles en el tratamiento de trastornos como aterosclerosis, resistencia a la insulina, artrosis, diabetes, enfermedad de alzheimer, entre otras.
BRPI0917920B8 (pt) expansão direcional de dispositivos intraluminais
CL2013000933A1 (es) Compuestos derivados de furo[3,2-d]pirimidina y sus sales; composicion farmaceutica que los comprende; y su uso para tratar una afeccion que esta mediada por la actividad de una proteina quinasa, tal como cancer, trastornos cardiovasculares, del snc e inmunes, y enfermedades relacionadas con la inmunodeficiencia adquirida.
HRP20141081T1 (hr) Tikagrelor za lijeäśenje aneurizme abdominalne aorte
AR069325A1 (es) Proceso para preparar sales de dibenzoil - l - tartrato
DOP2014000078A (es) Profármaco de adrenomedulina basado en polietilenglicol y su uso
ITTO20040410A1 (it) Procedimento per la fabbricazione di travi strutturali in composito per aeromobili.
EA201892150A1 (ru) Распадающиеся в полости рта таблетки
UY29009A1 (es) Nuevos derivados de pirimidina, sales y solvatos farmaccuticamente aceptables de los mismos, composiciones, procedimientos para su preparacinn y uso.
ATE506040T1 (de) Intravaskulärer stent
WO2008137733A3 (en) Micellar structures, methods of making micellar structures, methods of imaging, and methods of delivering agents
MX393334B (es) Administración subcutánea de un antagonista del receptor p2y12.
UY30880A1 (es) 7-alcoxicinolin-3-carboxamidas sustituidas y sales farmacéuticamente aceptables de las mismas, procedimientos de preparacion y aplicaciones
PA8793401A1 (es) Nuevos tetrahidronaftalenos sustituidos, procedimiento para su preparación y uso de los mismos como medicamentos
EA024825B8 (ru) Сокристалл тикагрелора с 3-гидрокси-2-нафтойной кислотой, способ его получения и применение